Kumamoto, Japan

Keizo Sato

This inventor holds 1 USPTO granted patent. Top assignee: Dojindo Laboratories. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keizo Sato. Retrieved from https://idiyas.com/inventor/keizo-sato-girbhpgl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keizo Sato: Innovator in Cardiovascular Therapeutics

Introduction

Keizo Sato is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of cardiovascular therapeutics through his innovative research and development of novel compounds.

Latest Patents

One of his key inventions is related to imidazolinoxyl derivatives. This patent presents compounds that exhibit a long-acting coronary blood vessel dilating action. The compounds can be directly administered after dilution with a suitable concentration of a phosphate buffer. They provide a significant and long-lasting relaxing effect on blood vessels, despite being quickly inactivated and excreted in blood flow, with no noted side effects.

Career Highlights

Keizo Sato is associated with Dojindo Laboratories, where he has been instrumental in advancing research in his field. His work has led to the development of innovative solutions that address critical health issues related to cardiovascular function.

Collaborations

He has collaborated with notable colleagues such as Ryusuke Tsunoda and Hiroshi Maeda, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Keizo Sato's contributions to the field of cardiovascular therapeutics through his patented inventions highlight his role as a significant innovator. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…